Article Details

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2022

Retrieved on: 2022-07-29 18:34:41

Tags for this article:

Click the tags to see associated articles and topics

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2022. View article details on hiswai:

Excerpt

... statements regarding the potential of IPA's PolyTope monoclonal antibodies, including TATX-03, to provide strong anti-viral effects against ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up